Kaiser Family Foundation/ Harvard School of Public Health Medicare Prescription Drug Survey
A new survey by the Kaiser Family Foundation and Harvard School of Public Health examines public opinion on the current Medicare prescription drug debate.
View the Latest: Prescription Drugs
Filter
-
-
National ADAP Monitoring Project: Annual Report March 2000
Other PostThis report, the fourth in an annual series, provides an overview of the status of state-administered AIDS Drug Assistance Programs (ADAPs).
-
Prospects for Retiree Health Benefits as Medicare Drug Coverage Begins
Poll FindingFindings from the Kaiser/Hewitt 2005 Survey on Retiree Health Benefits The 2005 Kaiser/Hewitt survey of large businesses that provide retiree health benefits to their workers assesses their responses to the new Medicare drug benefit in 2006, their plans for the future, and the way these changes affect retirees.
-
State Financing of the Medicare Drug Benefit: New Data on the “Clawback”
Issue BriefState Financing of the Medicare Drug Benefit: New Data on the "Clawback" Beginning in 2006, states will be obligated to finance part of the new Medicare prescription drug benefit via a monthly "clawback" payment to the federal government.
-
The Impact of Cost Sharing on Appropriate Utilization and Health Status: A Review of the Literature on Seniors
Other PostThe Impact of Cost-Sharing on Appropriate Utilization and Health Status: A Review of the Literature on Seniors This article provides a review of research that has addressed the impact of patient cost-sharing on the use of health care services and subsequent health status for those ages 65 and older.
-
Health Care Agenda for the New Congress
Poll FindingThis survey captures the public's attitudes regarding the health care agenda for Bush's second term and the new Congress in 2005.
-
Summary of the Proposed Rule to Implement the New Medicare Prescription Drug Benefit
Issue BriefIn August 2004, the Centers for Medicare and Medicaid Services published a proposed rule to implement the Medicare Prescription Drug Benefit (Title I of the Medicare Modernization Act).
-
Impact of Pharmaceutical Promotion on the Use of Antidepressant Medication
Other PostTwo recent articles have been published on the impact of direct-to-consumer advertising (DTCA) on the use of antidepressants, based on research by researchers at Harvard University and the Massachusetts Institute of Technology, and funded in part by the Kaiser Family Foundation.
-
The Effect of Formularies and Other Cost Management Tools on Access to Medications: An Analysis of the MMA and Proposed Regulations
Issue BriefThis paper, by John F. Hoadley, Ph.D., of the Health Policy Institute at Georgetown University, examines how formulary designs and other cost-management tools may affect Medicare beneficiaries’ access to medications through their Medicare Part D prescription drug plans.
-
Health Care and the 2004 Elections
Other Post** Update: For information on health care and the 2008 election, visit www.health08.org. ** Health care issues continue to be important for many Americans and a vital part of the policy debates in Washington and around the country.